Chivukula Lab
Scanning electron micrograph of airway cilia

Center for Genomic Medicine, Massachusetts General Hospital
Harvard Medical School

Leveraging rare disease genetics to illuminate specialized cell biology

We use molecular biology, biochemistry, and animal modeling to investigate mechanisms underlying human genetic disorders. We are particularly interested in rare Mendelian diseases that dysregulate the biogenesis and function of specialized cells and subcellular compartments.

News

  • September 2026 Raghu is awarded the Howard M. Goodman Fellowship by Mass General Brigham.
  • August 2026 The lab receives a five-year R01 award from the National Institute of Neurological Disorders and Stroke to study tRNA biogenesis defects in neurodegeneration.
  • July 2026 Xincheng Wu joins the lab as a postdoctoral fellow.
  • May 2026 Zhirou Lian and Navya Jain join the lab.
  • April 2026 Raghu and Dr. Alesi (Brigham and Women's Hospital) receive a BWH-MGB Collaborative IGNITE Award for work on lysosomal exocytosis as a therapeutic target in lymphangioleiomyomatosis.
Earlier
  • April 2026 A U.S. patent is issued for the use of NEK10 in treating and diagnosing bronchiectasis and other respiratory disorders.
  • March 2026 Raghu is named Associate Director of the Center for Genomic Medicine.
  • August 2025 Max Valenstein's structural work on amino acid sensing by mTORC1, with the Sabatini and Rogala labs, is published in Nature. Read more
  • July 2025 Our paper showing that polyglycine aggregation of FAM98B disrupts tRNA processing in GGC repeat disorders is published in Science. Read more
  • June 2025 Raghu receives the Mark C. Fishman, M.D. Teaching Award from the MGH Department of Medicine.
  • February 2025 David Ziehr is awarded a Parker B. Francis Fellowship for his work on pulmonary fibrosis.
  • January 2025 Max Valenstein's paper showing that amino acids and KLHL22 do not activate mTORC1 through DEPDC5 degradation, with the Sabatini lab, is published in Nature. Read more
  • August 2024 Max Valenstein's paper on Rag-Ragulator as the organizer of the mTORC1 nutrient-sensing pathway, with the Sabatini lab, is published in PNAS. Read more
  • May 2024 Lab alumnus Jason Yang, now a genetics PhD student at Stanford, is named a Hertz Fellow for his work on repeat expansion disorders. Read more
  • April 2024 Raghu is named a Department of Medicine Transformative Scholar, supported by the Tianqiao and Chrissy Chen Institute.
  • March 2024 The lab receives the Smith Family Award for Excellence in Biomedical Research for mechanistic studies of GGC repeat expansions.
  • November 2023 Raghu receives the Ellison Foundation Award.
  • September 2023 Raghu is named Co-Director of the MGH Adult Pulmonary Genetics Clinic.
  • August 2023 Our work with the Bartel lab showing that ZSWIM8 destabilizes many microRNAs and is required for embryonic development is published in Genome Research. Read more
  • March 2023 Raghu is named an Associate Member of the Broad Institute of MIT and Harvard.
  • February 2023 Raghu receives the ASCI Young Physician-Scientist Award.
  • January 2023 The lab opens in the Center for Genomic Medicine at MGH.

Research

Our lab is grounded in the belief that rare human genetic disorders can illuminate fundamental principles in cell biology and reveal new treatments for common and uncommon disease alike. These ideas have already paid huge dividends in heart disease and cancer and are growing in scope as medical practice increasingly incorporates molecular genetics.

We are currently most interested in monogenic disorders of proteostasis and organelle quality control. Proteostasis and organellar defects, often manifested by subcellular protein aggregation, are common during aging and across diverse human disease states, yet their molecular basis is hard to uncover because model systems are limited and the initiating events in complex, often age-related disease are poorly understood. We take a genetics-driven approach: we study human syndromes that phenocopy sporadic proteostasis and organellar diseases but have a single defined cause that is amenable to mechanistic work in the laboratory, using cultured immortalized cells, primary human stem cell cultures, and mouse models together with biochemistry, mass spectrometry, advanced microscopy, and functional genomics.

Scanning electron micrographs of airway ciliaSanger trace showing a NEK10 mutationImmunofluorescence of airway epithelium

Familial bronchiectasis

Bronchiectasis describes a family of related pulmonary disorders caused by failure of airway mucociliary clearance. In most cases the underlying cause remains unknown and there are few effective therapies. We are leveraging familial forms of the disease to identify genetic mechanisms that initiate and exacerbate bronchiectasis. In earlier work, we showed that loss of a previously orphan protein kinase, NEK10, causes bronchiectasis through defects in the growth and assembly of airway cilia, the specialized organelles that drive mucociliary clearance. We continue to work on the molecular basis of this and other forms of Mendelian airway disease using molecular genetics and biochemistry in airway culture systems.

Lamp1 and HA immunofluorescence in mouse lungImmunoblots of lung lysosome immunoprecipitationVolcano plot of lung lysosome proteomics

Hereditary pulmonary fibrosis

Pulmonary fibrosis is an incurable disorder caused by a large, heterogeneous, and poorly understood family of interstitial lung diseases. Rare familial forms are caused by mutations in factors required for the biogenesis and trafficking of specialized organelles unique to the lung, and are accompanied by accumulation of aggregated proteins and lipids within these compartments. We have developed new methods for purifying and analyzing these organelles from genetically engineered mice and are working to understand their biochemical roles in lung disease.

Electron micrograph of an intranuclear inclusionGel of aggregate-associated proteinsNorthern blots of tRNA processing intermediates

Mendelian neurodegeneration

Pathogenic expansions of GGC trinucleotide repeats cause a family of related neurodegenerative disorders typified by intranuclear aggregates. The composition and cellular consequences of these aggregates were unclear, as was why GGC repeat diseases specifically affect the brain. We developed methods to address these questions and found that polyglycine aggregation sequesters FAM98B and disrupts tRNA processing. We are now working out the molecular details of this process and, more broadly, the role of tRNA dysregulation in human disease.

Team

Raghu Chivukula, MD, PhD

Principal Investigator

Raghu Chivukula, MD, PhD

Raghu is Assistant Professor of Medicine and Surgery at Harvard Medical School, Associate Director of the Center for Genomic Medicine at Massachusetts General Hospital, and Associate Member of the Broad Institute of MIT and Harvard. He attends in the MGH intensive care unit and co-directs the MGH Adult Pulmonary Genetics Clinic.

He trained at Johns Hopkins (BA, MD, PhD), completed internal medicine residency at MGH and pulmonary and critical care fellowship at Harvard, and was a postdoctoral fellow at the Whitehead Institute. His work has been recognized by the Burroughs Wellcome Career Award for Medical Scientists, the Smith Family Award for Excellence in Biomedical Research, and the ASCI Young Physician-Scientist Award. Outside the lab and hospital he can be found trying to convince his kids to go climbing with him and coaxing his 1975 Porsche 911 to start.

Curriculum vitae (PDF)

  • Coleen Cunningham

    Coleen Cunningham

    Senior Project Coordinator

    Coleen manages the day-to-day operations of the lab and is the first point of contact for administrative questions.

  • David Ziehr, MD

    David Ziehr, MD

    Postdoctoral Fellow

    After medical school at Harvard, David completed clinical training in pulmonary and critical care medicine at MGH. He is interested in the molecular pathophysiology of pulmonary fibrosis.

  • Xincheng Wu, PhD

    Xincheng Wu, PhD

    Postdoctoral Fellow

    Xincheng joined the lab in 2026 after completing his PhD at Cornell University. His expertise is in ribosome profiling and translation biology.

  • Max Valenstein, MD, PhD

    Max Valenstein, MD, PhD

    Pulmonary and Critical Care Fellow

    After undergraduate training at Yale, Max completed the Harvard/MIT MD-PhD program and internal medicine residency in the MGH Stanbury physician-scientist program. He is now a clinical fellow in pulmonary and critical care medicine.

  • Zhirou Lian

    Zhirou Lian

    Research Technician

    Zhirou studied neuroscience and computer science at Wellesley College and worked in the Feng lab at MIT's McGovern Institute on viral tools for targeting specific neuronal cell types. In the lab she studies mechanisms underlying dysregulated translation in genetic disease states, and she plans to pursue a PhD.

  • Jack Bush

    Jack Bush

    Research Technician

    Jack has a background in marine biology and built the lab's mouse genetic models of lung disease. He completed his nursing degree at the MGH Institute of Health Professions and is now an ICU nurse at MGH, and he still helps manage the lab's mouse colony.

  • Navya Jain

    Navya Jain

    Master's Student, Northeastern

    Navya is a master's student in biotechnology at Northeastern University and joined the lab through its co-op program. She studied biotechnology at Shiv Nadar University in India, where her thesis work examined fibroblast activation in systemic sclerosis. In the lab she studies patient mutations and their effects on airway physiology.

Alumni

  • Lillie Chudacoff Summer student Now: PhD candidate in Chemistry, University of Iowa
  • Ben Hirschberg Summer student Now: Undergraduate, University of Massachusetts
  • Kate Rutter Summer student Now: Undergraduate, Brigham Young University
  • Yunhan (Forrest) Xu Research Technician Now: Medical student, University of Melbourne
  • Jason Yang Research Technician Now: PhD student in Genetics, Stanford; Hertz Fellow

Publications

Selected

All publications

2025

2024

2023

2022

2021

2020

2018

2015

2014

2012

2011

  • Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice Pramanik D, Campbell N, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A Molecular Cancer Therapeutics 2011

2010

2009

2008

2004

  • Visual illusion in virtual world alters women's target-directed walking Chaudhury S, Eisinger J, Hao L, Hicks J, Chivukula R, Turano K Experimental Brain Research 2004

Join us

We are always looking for curious, talented, and motivated people to join the group. If you are interested in Mendelian genetics, cell biology, and human disease, we would love to connect. Prospective research technicians, students, postdoctoral fellows, clinical fellows, and staff scientists should email Raghu to discuss potential opportunities and projects.

Email Raghu

Support the lab

We are deeply grateful for philanthropic support of our work, and no gift is too small.

Give through Mass General

Our work is supported by the National Institute of Neurological Disorders and Stroke, the Burroughs Wellcome Fund, the Smith Family Foundation, the Ellison Foundation, the Tianqiao and Chrissy Chen Institute, the Francis Family Foundation, and Massachusetts General Hospital.

Contact

rchivukula@mgh.harvard.edu

Simches Research Building, CPZN 6.256
185 Cambridge Street
Boston, MA 02114

Affiliations